| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000205500.4 |
ABT-263 (navitoclax) |
Breast invasive carcinoma |
0.019597495 |
Sensitive |
| ENSG00000205500.4 |
ABT-263 (navitoclax) |
Colon adenocarcinoma |
0.048424432 |
Sensitive |
| ENSG00000205500.4 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.007718629 |
Sensitive |
